LAVAL, QC, Jan. 26 /CNW/ - BioSyntech, Inc. (TSX: BSY), a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that Dr. Amine Selmani has resigned from its Board of Directors effective January 23, 2009. Dr. Selmani is the founder of BioSyntech and was its Chief Executive Officer from 1995 to 2004 and subsequently Chairman of the Board of Directors until 2006. He has also managed BioSyntech’s broad intellectual property portfolio since the Company’s inception. Dr Selmani will remain available as an advisor to the Board of Directors.
